Non-alcoholic fatty liver disease (NAFLD) is a condition caused by the buildup of excess fat in the liver. It is a common condition and affects up to one in five people in the United States. NAFLD is associated with obesity, diabetes, and other metabolic disorders. It is typically asymptomatic and can lead to more serious conditions, such as cirrhosis and liver cancer. NAFLD is often seen in people with metabolic syndrome, which includes conditions such as obesity, high blood pressure, high triglycerides, and low levels of "good" cholesterol. These conditions are associated with insulin resistance, which can lead to NAFLD. Other risk factors for NAFLD include a high-fat diet, sedentary lifestyle, and certain medications, such as those used to treat high cholesterol or diabetes. NAFLD can also be seen in people who are not obese or have metabolic syndrome. Other diseases that may be associated with NAFLD include autoimmune conditions such as lupus, rheumatoid arthritis, and celiac disease; certain genetic diseases such as hemochromatosis and Wilson's disease; and certain viral infections such as Hepatitis C. The main treatment for NAFLD is lifestyle modification. This includes eating a healthy diet, exercising regularly, and maintaining a healthy weight. If necessary, medications such as statins may be used to reduce cholesterol and other fats in the blood. In some cases, liver transplantation may be necessary. It is important to consult with your doctor if you have any of the conditions associated with NAFLD. Early diagnosis and treatment can help prevent more serious complications, such as cirrhosis and liver cancer.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China